Dupilumab (Dupixent®) recommended for restricted use within NHS Wales in children age 6 to 11 years

This is recommended for the treatment of severe atopic dermatitis in children age 6 to 11 years who are candidates for systemic therapy and where existing systemic therapies are not advisable.

All Wales Medicines Strategy Group